All In Biotech

Free tool

FAERS Monitor: Smoflipid 20%

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207648 or its brand name (Smoflipid 20%, Fish Oil, Medium Chain Triglycerides, Olive Oil, Soybean Oil). Reports on generic versions are filed under their own applications.

Reports

874

Serious

665

76% of reports

Hospitalization

350

Death reported

105

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pyrexia58
  • vomiting53
  • off label use52
  • nausea51
  • malaise41
  • dyspnoea38
  • death36
  • intentional product use issue34
  • chills31
  • fatty acid deficiency31
  • hypertriglyceridaemia31
  • diarrhoea29
  • cholestasis27
  • parenteral nutrition associated liver disease25
  • product use issue25

Reports by year received

View as table
YearReports
20111
20122
201410
20158
201634
201778
2018121
201998
202064
202168
202260
202391
202493
202575
202671

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,285 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
fatty acid deficiencySignal3114642.09416.6273,234
parenteral nutrition associated liver diseaseSignal259409.55955.0162,427
hypertriglyceridaemiaSignal31128.190.63,765
cholestasisSignal2733.923.4829
intentional product use issueSignal349.36.7246
chillsSignal316.44.5136
pyrexiaSignal584.03.1131
product use issueSignal253.22.236
vomitingSignal532.72.157
malaiseSignal412.21.728
dyspnoea381.61.29
nausea511.61.210
off label use521.41.17
diarrhoea291.10.80
death361.00.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.